Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1994-03-14
1997-12-23
Kight, John
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536 256, 536 252, 514 47, A61K 3170, C07H 2102
Patent
active
057007853
ABSTRACT:
Synthetic analogs of 2',5'-oligoadenylate wherein the aglycon, ribosyl moiety and/or terminal nucleoside have been modified are effective therapeutic agents, particularly against HIV infection. The analogs are utilized in compositions and methods for the treatment of disorders characterized by 2-5A pathway defects.
REFERENCES:
patent: 4210746 (1980-07-01), Kerr et al.
patent: 4464359 (1984-08-01), Suhadolnik et al.
patent: 4539313 (1985-09-01), Suhadolnik et al.
patent: 4654326 (1987-03-01), Devash et al.
patent: 4824941 (1989-04-01), Gordon et al.
patent: 4855304 (1989-08-01), Devash
patent: 4859768 (1989-08-01), Suhadolnik et al.
patent: 4981957 (1991-01-01), Lebleu et al.
Liu et al., "Inhibition of Viral Reverse Transcriptase by 2',5'-Oligodenyes," Biochem. Biophys. Res. Comm, 145(1), 291-297(1987).
Henderson et al., "Inhibition of Epstein-Barr Virus-Associates Nuclear Antigen (EBNA) Induction by (2',5')-Oligoadenylates and the Cordecypin Analog: Mechanism of Action for Inhibition by EBV-Induced Transformation," Virology, 122(1), 198-201 (1982).
Lee et al., "Inhibition of Protein Synthesis by the Cordycepin Analog of (2'-5')ppp(Ap).sub.n A, (2',5')ppp(3'dAp).sub.n 3'dA, in Intact Mammalian Cells," FEBS Letters, 157, 205-209 (1983).
Suhadolnik et al. (IV), "Analogs of 2',5'-Oligoadenylates: Biological Probes for the Antiviral/Antitumor State of Mammalian Cells," Nucleosides, Nucleotides and Their Biological Applications, pp. 147-149, Nov. 1983.
Chapekar et al., "Cordycepin Analog of (A2'p).sub.2 A: Evidence That It Functions as a Prodrug of Cordycepin," Biochem. Biophys. Res. Comm., 115, 137-143 (1983).
Eppstein et al., "Mechanism of Antiviral Activity of (XyloA2'p).sub.2 XyloA," Virology, 131, 341-354 (1983).
Eppstein et al. (II), "Analogs of (A2'p).sub.n A," J. Biol. Chem., 257, 13390-13397 (1982).
Hughes et al., "2',5'-Oligoadenylates and Related 2',5'-Oligonucleotide Analogues. 2. Effect of Cellular Proliferation, Protein Synthesis, and Endoribonuclease Activity," Biochemistry, 22, 2127-2135 (1983).
Sharma et al., "3'-O-Methylated Analogs of 2-5A as Inhibitors of Virus Replication," FEBS Letters, 158, 298-300 (1983).
Engels et al., "Synthesis of 2'-End Modified 2',5'-Adenylate Trimers," Tett. Lett., 21, 4339-4342 (1980).
Charubala et al., "Synthesis of Inosinate Trimer I2'p5'I2'p5'I and Tetramer I2'p5'I2'pI2'p5'I2," Tett. Lett., 23, 4789-4792 (1982).
Haugh et al., "Analogues and Analogue Inhibitors of ppp(A2'p).sub.n A, Their Stability and Biological Activity," Eur. J. Biochem., 132, 77-84 (1983).
Justesen et al., "Elongation Mechanism and Substrate Specificity of 2',5'-Oligoadenylate Synthetase," Proc. Nat. Acad. Sci. USA, 77, 4618-4622 (1980).
Baglioni et al., "Analogs of (2'-5')OligoA," J. Biol. Chem., 256, 3253-3257 (1981).
Torrence et al., "Only One 3'-Hydroxyl Group of ppp5'A2'p5'A2'p5'A(2-5)A Is Required for Activation of the 2-5A-Dependent Endonuclease," Biochem. Biophys. Res. Comm., 145, 291-297 (1987).
Sobol et al., "Human Immunodeficiency Virus Reverse Transcriptase: Inhibition by Structurally and Sterochemically Modified Analogs of 2-5A," FASEB Journal, 2, A830, Abstr. #3102 (1988).
Suhadolnik et al., "Inhibition of HIV-7 Reverse Transcriptase . . . ," Abst. #3582, IV International Conference on AIDS, Jun. 12, 1988.
Gura, "Antisense Has Growing Pains--Efforts to Develop Antisense Compounds as Therapies for Cancer, AIDS, and Other Diseases Have Encountered Some Unexpected Questions About How the Drugs Really Work," Science, 270, 575-577 (1995).
Visser et al., "Synthesis of some modified 2'-5'-linked oligoriboadenylates of 2-5A core" Recl. Trav. Chim. Pay-Bas 105, 85-91 (1986).
Pfleiderer Wolfgang
Suhadolnik Robert J.
Crane L. Eric
Kight John
Temple University - Of The Commonwealth System of Higher Educati
LandOfFree
3'-deoxy or 3'-O-substituted-2',5'-oligoadenylates as antiviral does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3'-deoxy or 3'-O-substituted-2',5'-oligoadenylates as antiviral , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3'-deoxy or 3'-O-substituted-2',5'-oligoadenylates as antiviral will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1802844